Pharma-Skan & Skan-Medic have been acquired by Brygge Partners

Pharma-Skan, an independent contract manufacturing organization (CMO), and Skan-Medic, a manufacturer of over-the-counter (OTC) products, both operating as a joint entity, have been acquired by Brygge Partners.

Pharma-Skan is a Danish CMO serving large corporations in the pharmaceutical and life sciences industries. With 45 years of consistent performance, the company specializes in the production, filling and packaging of liquid and sterile pharmaceuticals and oral liquids, as well as handling raw materials for both human and veterinary applications.

Skan-Medic, also based in Denmark, manufactures a range of OTC creams, lotions, ointments and other pharmacy-related products, including the patented Marselisborg Cream skin lotion, sold to pharmacies in Denmark.

The product portfolio includes both private label products and recurring contract work for large international pharmaceutical companies, such as the patented potassium chloride oral solution used to treat potassium deficiency, surface disinfectant ethanol for industrial cleaning and boar semen extenders. Operations are carried out in dedicated rooms for each stage of the process — sterile manufacturing, galenic formulation, packaging and quality control — backed by an experienced team with deep industry knowledge.

Brygge Partners is a Danish family office focused on long-term, mid-market acquisitions in the Nordic region, taking a hands-on approach to nurture and develop its portfolio companies.

Oaklins’ team in Denmark acted as the strategic and financial advisor to the owners of Pharma-Skan and Skan-Medic in this transaction.